Neurizon Therapeutics Limited (ASX:NUZ)
Australia · Delayed Price · Currency is AUD 0.0600
-0.0010 (-1.64%)
Jun 5, 2026, 4:10 PM AEST
Neurizon Therapeutics Market Cap
Neurizon Therapeutics has a market cap or net worth of 44.78 million as of June 5, 2026. Its market cap has decreased by -41.32% in one year.
Market Cap
44.78M
Enterprise Value
38.45M
Revenue
5.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since September 12, 2002, Neurizon Therapeutics's market cap has increased from 4.18M to 44.78M, an increase of 970.39%. That is a compound annual growth rate of 10.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 44.78M | -1.68% |
| Dec 31, 2025 | 45.54M | -45.58% |
| Dec 31, 2024 | 83.69M | 94.55% |
| Dec 29, 2023 | 43.02M | 112.09% |
| Dec 30, 2022 | 20.28M | -36.00% |
| Dec 31, 2021 | 31.69M | -4.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cynata Therapeutics | 73.04M |
| Radiopharm Theranostics | 69.11M |
| LTR Pharma | 66.35M |
| Botanix Pharmaceuticals | 59.85M |
| Amplia Therapeutics | 59.03M |
| Entropy Neurodynamics | 53.85M |
| Nexsen | 47.05M |
| Avecho Biotechnology | 42.13M |